Introduction
============

The liver is a vital organ that plays a key role in the detoxification of exogenous and endogenous substances. It also performs a wide range of metabolic activities required for homeostasis, nutrition and immune defense ([@b1-ijsc_07_87]). A variety of pathological factors including viral hepatitis (especially hepatitis B and C), alcohol and drug abuse, metabolic diseases, autoimmune diseases and congenital abnormalities can cause hepatic injury. Lifestyle changes, mainly exercise withdrawal and weight gain, have probably raised the prevalence of non- alcoholic fatty liver diseases, which is one of the causes of chronic liver diseases ([@b2-ijsc_07_87]). Liver fibrosis is the final stage of all chronic hepatic disease. It is a well-known fact that fibrosis has lots of important complications such as portal hypertension, hepatocellular carcinoma, hepatic encephalopathy, spontaneous bacterial peritonitis and hepato-renal syndrome ([@b3-ijsc_07_87]). Liver transplantation is the treatment of choice for end-stage liver diseases, however, it faces several difficulties, including donor shortage, surgery-related complications, immunological rejection and high medical cost. Cell transplantation therapy would be the minimally invasive and alternative methods with fewer complications ([@b4-ijsc_07_87]).

Mesenchymal stem cells were described as multi-potent because of their ability for differentiation into a variety of different cells and tissue lineages. MSCs could be differentiated into epithelial cells of the liver, kidney, lung, skin, gastrointestinal tract, myocytes of heart, skeletal muscles, chondrocytes, osteoblasts, adipocytes, fibroblasts and other tissues of mesenchymal origin ([@b5-ijsc_07_87]). They could also differentiate into functional hepatocyte-like cells ([@b6-ijsc_07_87]). Previous studies showed that BM-MSCs could engraft injured liver tissue and recover its function ([@b7-ijsc_07_87]). More over MSCs exhibited a greater homing capability for the injured liver than did hematopoietic stem cells ([@b8-ijsc_07_87]). So the aim of this work was to evaluate the effect of BM-MSCs on the liver structure of experimental model of liver fibrosis in rats.

Materials and Methods
=====================

Animals
-------

Twenty young male albino rats (5∼6 weeks) weighing 120∼140 gm and sixty adult female albino rats (6∼8 weeks) with average weight 200 gm were used in this study. The animals were purchased and raised in the Medical Research Center Ain Shams University. They were housed in plastic cages with mesh wire covers and were given food and water ad libitum. The rats were killed according to the Ethics Committee recommendations of Ain Shams University.

Chemicals
---------

Dulbecco's modified Eagle's medium (DMEM), fetal bovine serum (FBS), penicillin-streptomycin solution, and 0.25% trypsin − 0.02% EDTA solution were purchased from Lonza Company, Swiss. The monoclonal mouse human antibody for CD44, CD 29, CD 34, Alpha smooth muscle actine (*α*- SMA), Proliferating cell nuclear antigen (PCNA) and biotinylated goat anti-mouse secondary antibody were purchased from LABVISION USA. Carbon tetrachloride (CCL4) (concentration 100%) and olive oil were obtained from Algomhoria Company.

Culture and characterization of BM-MSCs
---------------------------------------

The BM were harvested from the twenty male albino rats. The BM was flushed out from the diaphysis of femoral and tibia bones with 2 mL of complete medium, consisting of 80 ml DMEM, 15 ml FBS and 5 ml of Penicillin/streptomycin mixture. The marrow plugs were expelled from the opposite ends of diaphysis into the sterile petri dish. The culture dishes, containing the BM cells, were incubated in a humidified incubator at 37°C in 5% CO2 and 95% air (by volume). Every two days, The exchange of media was done. On day nine from the isolation and culture, when the cultured cells became confluent, the MSC in culture were characterized by their adhesiveness and fibro-blast like shape ([@b9-ijsc_07_87]). We also use streptavidin-biotin immune-peroxidase technique for detection of CD44, CD 29 and CD 34 gene expression. MSCs are CD44, CD 29 positive and CD 34 negative while hematopoietic cells are CD 34 positive ([@b10-ijsc_07_87]).

Preparation of BM-MSC for intra-peritoneal administration
---------------------------------------------------------

On day nine of isolation and culture, after being sure that the cultured cells were MSCs, The cells were detached by adding 0.3 ml Trypsin EDTA solution for 10 minutes. The cell suspension was centrifuged and the cell pellets were obtained. 0.1 ml of cell pellet was mixed with 0.1 ml of trypan blue suspension for 5∼15 minutes. The live cells do not take up the dye, whereas dead cells do ([@b11-ijsc_07_87]). A sample of Trypan blue-cell suspension was dispensed on top of a hemocytometer slide so that the fluid entirely covered the surface of the squares of the slide. The number of viable and non-viable cells in each square was then counted, using the ordinary light microscope. The cell concentration was calculated as follows: Cells/ml= average cell count per square×dilution factor×10^4^ ([@b12-ijsc_07_87]). Total cells in the original solution=cells/ml×the original volume of fluid from which the cell sample was removed. % Cell viability=total viable cells (unstained)/total cells× 100. In the current study, Average cell count in one square was 15 Living cells and 5 dead cells, Dilution factor= 2, the original volume of fluid from which the cell sample was removed=10 ml. So, Cells/ml=20×2×10^4^=4×10^5^. Total cells in the original solution=4×10^5^×10=4×10^6^. % Cell viability=15/20×100=75%. Total viable cells were injected in each rat=4×10^6^×75%=3×10^6^.

CCl4-induced liver fibrosis model
---------------------------------

Thirty female albino rats were injected by CCL~4~ (0.5 mg/kg of body weight) twice weekly for four weeks intraperitoneal (I.P.). The solution for injection were formed of 100 mg of CCL~4~ dissolved in 100 ml of olive oil. Each rat was received 0.1 ml of CCL~4~ dissolved in olive oil ([@b13-ijsc_07_87]).

Experimental groups
-------------------

**Group I (control group):** Thirty female albino rats were equally subdivided into three subgroups: - **Subgroup IA**: Rats were used to collect liver specimen as a negative control group.- **Subgroup IB**: Each rat was given 0.1 mL of olive oil by IP injection twice weekly for four weeks then the rats were sacrificed.- **Subgroup IC**: Each rat was given 0.1 mL of olive oil by IP injection twice weekly for four weeks. Then the rats were injected by a single IP dose of 0.5 mL phosphate buffer saline (PBS). Then the rats were sacrificed after another four weeks.

**Group II:** Thirty female albino rats were injected CCL4 to induce liver fibrosis as scheduled above. Then rats were equally subdivided into the following three subgroups; subgroup IIA (CCL4 alone group) was sacrificed immediately at the end of this four weeks. subgroup IIB (CCL4/MSCs group) was injected I.P. by a single dose 3×10^6^ of BM-MSCs suspended in 0.5 ml PBS and was left for another four weeks. Subgroup IIC (CCL4/recovery group) was left for another four weeks without any intervention.

At the end of the experiment, the rats were sacrificed using ether anesthesia. Liver specimens were collected and processed for histological study. Blood samples were also collected for biochemical analysis.

Histological study
------------------

For light microscopic examination: Liver samples were collected and fixed in 10% buffered formalin for 24 hours. Serial 5-*μ*m paraffin sections were prepared and stained with hematoxylin and eosin (H&E), Masson Trichrome (MT) and immunohistochemical for Alpha smooth muscle actin (*α*-SMA) ([@b14-ijsc_07_87]) and Proliferating cell nuclear antigen (PCNA)([@b15-ijsc_07_87]).

For Transmission electron microscope (TEM) examination, Small liver specimens (1 mm^3^) were fixed in 2.5% gluteraldehyde solution. They were then post-fixed in 1% osmium tetroxide, dehydrated and embedded in Epon. Ultrathin sections were cut, stained with uranyl acetate and lead citrate and then examined using TEM1010- EXII (Joel, Tokyo, Japan) at the electron microscopic unit Unit, Faculty of Science, Ain Shams University., Cairo, Egypt.

PCR detection of male-derived MSC
---------------------------------

Genomic DNA was prepared from liver tissue homogenate of the rats in each group using QIAamp^®^ DNA Mini and Blood Mini KIT, Germany. The presence or absence of the sex determination region on the Y chromosome male (sry) gene in recipient female rats was assessed by PCR. Primer sequences for sry gene (forward 5′-CATCGAAGGGTTAAAGTGCCA-3′, reverse 5′-ATAGTGTGTAG-GTTGTTGTCC-3′) were obtained from published sequences ([@b16-ijsc_07_87]) and amplified a product of 104 bp was purchased from (Sigma-USA). The PCR conditions were as follows: incubation at 94°C for 4 min; 35 cycles of incubation at 94°C for 50 s, 60°C for 30 s, and 72°C for 1 min; with a final incubation at 72°C for 10 min. PCR products were separated using 2% agarose gel electrophoresis and stained with ethidium bromide. Positive (male white albino rat genomic DNA) and negative (female white albino rat genomic DNA) controls were included in each assay. Y chromosomes marker detected as Transilluminated line.

Biochemical analysis
--------------------

Blood samples were collected to measure the level of Aspartate aminotransferase (AST), Alanine aminotransferase (ALT) and Serum albumin. They were determined spectrophometrically with an automatic analyzer using commercially available kits in Dr. Ali Khalifa Chemical Lab. Ain Shams University.

Morphometric analysis
---------------------

Using image analyzer at Faculty of dentistry, Ain shams University, Area percentage of collagen content using Masson's trichrome stain, Area percentage of *α*-SMA and the mean number of PCNA positive cells were measured. All parameters were measured in randomly chosen five fields/section in five sections in ten rats in each group at magnification 400.

Statistical analysis
--------------------

The morphometric and biochemical measurements are expressed as mean±SD. Significant differences were determined by using ANOVA and post hoc tests for multiple comparisons using SPSS 9.0 computer Software. Results were considered significant at p value≤0.05.

Results
=======

Light microscopic examination of the liver
------------------------------------------

Examination of H and E stained sections of all subgroups of control rats showed nearly the same histological picture. The hepatocytes were arranged in the form of branching and anastomosing cords that radiate from the central veins and were separated by blood sinusoids, which were lined by flat endothelial cells. The hepatocytes showed acidophilic cytoplasm with single central rounded vesicular nuclei and some of the cells were binucleated ([Fig. 1A](#f1-ijsc_07_87){ref-type="fig"}). In subgroupIIA (CCL~4~ alone group), most of the hepatocytes contained multiple, large cytoplasmic vacuoles and some hepatocytes had deeply acidophilic cytoplasm and deeply stained nuclei ([Fig. 1B](#f1-ijsc_07_87){ref-type="fig"}). After MSCs administration, remarkable improvement in the hepatocytes was noticed as they appeared nearly similar to that of the control rats. Only few hepatocytes appeared with slight vacuolated cytoplasm ([Fig. 1C](#f1-ijsc_07_87){ref-type="fig"}). On the other hand, in the CCL~4~/recovery group the liver was still markedly affected. Hepatocytes appeared with highly vacuolated cytoplasm and deeply stained nuclei ([Fig. 1D](#f1-ijsc_07_87){ref-type="fig"}).

In Masson\'s trichrome stained sections the parenchyma of the liver in control groups appeared to be supported with a stroma of very delicate meshwork of collagenous fibers. Few collagenous fibers surrounding the central veins, in portal area and in capsules were seen ([Fig. 2A](#f2-ijsc_07_87){ref-type="fig"}). In subgroupIIA (CCL~4~ alone group), the stroma was well defined. There was thick connective tissue capsule and an apparent increase in the collagen fibers around the central veins, in between hepatocyte cords and in portal areas ([Fig. 2B](#f2-ijsc_07_87){ref-type="fig"}). In CCL~4~/MSCs group, few collagen fibers were detected ([Fig. 2C](#f2-ijsc_07_87){ref-type="fig"}) while in the CCL~4~/recovery group the collagen fibers were very numerous ([Fig. 2D](#f2-ijsc_07_87){ref-type="fig"}).

Immune-stained sections for *α*-SMA showed few mildly immune-reacted *α*-SMA positive cells, in between the hepatocytes and around the central veins in the control groups ([Fig. 3A](#f3-ijsc_07_87){ref-type="fig"}). On the other hand, in CCL~4~ alone group numerous strong immune-reacted *α*-SMA positive cells were detected in-between the hepatocytes, around the central veins as well as in the connective tissue septa between the hepatic lobules ([Fig. 3B](#f3-ijsc_07_87){ref-type="fig"}). These cells showed intense positive brownish cytoplasmic reaction. They appeared as small spindle-shaped cell bodies with multiple cytoplasmic processes. These *α*-SMA positive cells were apparently few in CCL~4~/MSCs group ([Fig. 3C](#f3-ijsc_07_87){ref-type="fig"}) and markedly increased in the CCL~4~/recovery group ([Fig. 3D](#f3-ijsc_07_87){ref-type="fig"}).

Immune-stained sections for PCNA showed that few hepatocytes had a positive nuclear reaction in the control group ([Fig. 4A](#f4-ijsc_07_87){ref-type="fig"}), CCL~4~ alone group ([Fig. 4B](#f4-ijsc_07_87){ref-type="fig"}) and CCL~4~/recovery group ([Fig. 4D](#f4-ijsc_07_87){ref-type="fig"}). While the positive PCNA hepatocytes were many in CCL~4~/MSCs group ([Fig. 4C](#f4-ijsc_07_87){ref-type="fig"}).

The electron microscope examination of the liver
------------------------------------------------

Ultrathin sections of the control group showed adjacent hepatocytes with sinusoidal spaces in-between. Hepatic stellate cells (HSCs) were seen in the perisinusoidal space. The hepatocytes appear with large rounded, central vesicular nuclei (N). The nuclei showed usual characteristic chromatin distribution. The cytoplasm contained numerous mitochondria and prominent rough endoplasmic reticulum (rER) as well as fat droplets ([Fig. 5A](#f5-ijsc_07_87){ref-type="fig"}). In CCL~4~ alone group, The hepatocytes showed large vacuoles and many fat droplets in their cytoplasm and an apparent reduction of mitochondria and rER. The nuclei showed abnormal distribution of the chromatin ([Fig. 5B](#f5-ijsc_07_87){ref-type="fig"}). The liver of CCL~4~/MSCs rats showed that the structure of most of the hepatocytes was nearly comparable to that of the control group. Hepatocytes showed numerous mitochondria, rER. and glycogen granules. Some hepatocytes contained small vacuoles and few fat droplets ([Fig. 6A](#f6-ijsc_07_87){ref-type="fig"}). The hepatocytes of rats in CCL~4~/recovery group appeared highly vacuolated with many fat droplets and an apparent reduction in the mitochondria and rER. HSCs were frequently seen in-between hepatocytes with large euchromatic nucleus ([Fig. 6B](#f6-ijsc_07_87){ref-type="fig"}).

PCR detection of male-derived BMMSCs
------------------------------------

The SRY gene that was used as the Y chromosome marker was expressed in male rats from which BM-MSCs were isolated. It was also detected in female rats that were injected by male derived BM-MSCs in CCL~4~/MSCs group. Y chromosome marker was not detecting in the control group, CCL~4~ alone group and CCL~4~/recovery group ([Fig. 7](#f7-ijsc_07_87){ref-type="fig"}).

Morphometric results
--------------------

**The area percentage of both collagen and *α*-SMA** showed a significant increase (p\<0.001) in both CCL~4~ alone and CCL~4~/recovery groups as compared to the other groups. A significant increase (p\<0.001) in the area percentage of both collagen and *α*-SMA of CCL~4~/recovery group as compared to that of CCL~4~ alone group was detected. Non-significantly difference was noticed between the control and CCL~4~/MSCs groups ([Table 1](#t1-ijsc_07_87){ref-type="table"}).

**The mean number of PCNA positive cells/HPFs** was significantly high (p\<0.001) in the CCL~4~/MSCs group as compared to other groups. There was non-significantly difference in its level in control, CCL~4~ alone group and CCL~4~/recovery group ([Table 1](#t1-ijsc_07_87){ref-type="table"}).

Biochemical results
-------------------

**Serum ALT and AST** showed a significant high level (p\<0.001) in both CCL~4~ alone group and CCL~4~/recovery groups as compared to the other groups. The levels in the control and CCL~4~/MSCs were non-significantly different ([Table 1](#t1-ijsc_07_87){ref-type="table"}).

There was a significant reduction (p\<0.001) of serum albumin of rats of CCL~4~ alone and CCL~4~/recovery groups as compared to the other groups. While the levels in the control and CCL~4~/MSCs were non-significantly different and significantly high as compared to CCL~4~ alone and CCL~4~/recovery groups ([Table 1](#t1-ijsc_07_87){ref-type="table"}).

Discussion
==========

BM-MSCs are capable of homing to specific tissues, differentiate and stimulate a local repair response ([@b17-ijsc_07_87]). So this study was performed to investigate if the BM-MSCs could restore the liver structure in the experimental model of liver fibrosis. CCL~4~ was used in this study to induce liver fibrosis because among the different experimental animal models of liver fibrosis, the CCL~4~ model was the most closely resembling that of human liver cirrhosis ([@b18-ijsc_07_87]). Four weeks after CCL~4~ administration, light microscopic examination of the liver revealed loss of the usual hepatic architecture, many vacuoles with dark stained nuclei in most of the liver cells. Moreover, few mitochondria, few rER, many fat droplets and large irregular vacuoles were also detected by electron microscopic examination. This structural damage was due to edema of the organelles ([@b19-ijsc_07_87]) and explained the significant increase in serum AST and ALT and significant decrease in serum albumin, which were observed in the present work, as compared to the control. ALT and AST are useful serum markers for inflammation and necrosis of the liver ([@b20-ijsc_07_87]).

Liver fibrosis was clearly evidenced, in the present work, by a significant increase in area percentage of the collagen fibers in Masson trichrome stained section. The expression of *α*-SMA were determined as a marker for the activity of HSCs, which were identified as the primary cell type that mediate fibrogenesis ([@b20-ijsc_07_87]). So, immune-staining of *α*-SMA was done to detect the activity of HSCs. There was a significant increase in the area percentage of *α*-SMA positive cells in CCL~4~ alone group as compared to that of control group. This increase in the area percentage of *α*-SMA reflected an increase in the activity of HSCs. The *α*-SMA positive cells appeared as small spindle-shaped cell bodies with multiple cytoplasmic processes. HSCs are non-parenchymal quiescent cells for vitamin A storage in control liver. In pathological conditions as in liver fibrosis, HSCs lose retinoid, changes from the star-shaped stellate cells to myofibroblasts like cell and synthesize a large amount of extra cellular matrix components including collagen, proteoglycan and adhesive glycoproteins ([@b21-ijsc_07_87]). *α*-SMA is a good marker for the detection of this myofibroblasts like cells ([@b22-ijsc_07_87]). It was explained that hepatic fibrosis is usually initiated by hepatocytes damage leading to activation of Kupffer cells and subsequent release of cytokines and growth factors. These factors activate HSCs which proliferate and transform into myofibroblasts-like cells that deposit large amounts of connective tissue components ([@b23-ijsc_07_87]). Moreover, CCL~4~ causes oxidative stress that activates HSCs ([@b24-ijsc_07_87]).

Some of female rats with CCL~4~ induced liver fibrosis were treated with BM-MSCs (CCL~4~/MSCs group) while others were left without treatment (CCL~4~/recovery group). Our findings revealed that the liver structure of CCL~4~/recovery group was still affected. The light and electron microscopic picture of the hepatocytes and also the liver function were nearly similar to that of the CCL~4~ alone group. Moreover there was a progressive increase in the liver fibrosis. The area percentage of collagen fibers and *α*-SMA positive cells were significantly increased as compared to that of CCL~4~ alone group.

Intra-peritoneal route was chosen for BMMSCs injection in experimental fibrotic rats. The peritoneal cavity had long been used as a favorable site for therapeutic cell transplantation, with the advantage that large volume of cells can be implanted, technically easy to perform, less traumatic and less invasive ([@b25-ijsc_07_87]). The homing of the male donor cells were confirmed in the injured liver of female recipients by using PCR for the SRY gene. The Y-chromosome marker was expressed in female rats in CCL~4~/MSCs group. The presence of liver injury recruits homing of BM-MSCs through up regulating of cytokines such as stem cell factor-1, hepatocytes growth factor (HGF) and MMP and many of these cytokines and chemokines are chemo attractants ([@b26-ijsc_07_87]).

Light and electron microscopic examination of CCL~4~/MSCs group revealed an improvement of the liver structure. Most of hepatocytes appeared nearly as those of the control group and regained their function. Non-significant change was noticed in the level of ALT, AST and albumin in CCL~4~/MSCs group as compared to that were seen in the control groups. Similarly previous finding showed that transplanted BMMSCs could restore the serum albumin level and significantly suppressed transaminase activity and liver fibrosis in the injured liver of rats. BM-MSCs differentiated into hepatic oval cells and then to hepatocyte-like cells. The damaged hepatocytes were repaired and fibrosis was resolved, resulting in an overall improvement in liver function ([@b27-ijsc_07_87]).

The liver fibrosis was also resolved after BM-MSCs administration. The area percentage of the collagen fibers and area percentage of *α*-SMA positive cells were significantly decreased as compared to CCL~4~ alone group. BM-MSCs ameliorated liver fibrosis by down regulating the profibrotic genes and up-regulating anti-fibrotic hepatic genes ([@b28-ijsc_07_87]). Moreover, MSCs might play an inhibition role in process of HSCs transition from the quiescent state to activated state and induce HSCs apoptosis through release of interleukin-10 ([@b29-ijsc_07_87]). Recently, it was found that BM-MSCs reduced expression of collagen type I and *α*-SMA ([@b30-ijsc_07_87]).

Upon liver injury, the body attempts to repair the damage through increasing the expression of HGF, TGF-*β* and other cytokines to enhance hepatocytes proliferation and initiate tissue repairing process ([@b31-ijsc_07_87]). It was found that BM-MSCs secrete a variety of these cytokines and growth factors which suppress the local immune system, inhibit fibrosis and apoptosis, enhance angiogenesis and stimulate mitosis and differentiation of tissue-intrinsic stem cells ([@b32-ijsc_07_87]). PCNA immune-staining technique was used in the present study to detect the percentage of proliferating liver cells. The number of PCNA positive hepatocytes were significantly higher in the CCL~4~/MSCs group as compared to control, CCL~4~ and recovery group. This result could be explained by the previous findings which reported that the normal hepatocytes were generally quiescent and replicate in a limited and regulated manner. The replicative activity of hepatocytes diminishes in advanced cirrhosis in humans and in chronic liver injury in mouse, reaching a state of replicative senescence ([@b20-ijsc_07_87]). Infusion of BM-MSCs facilitated the proliferation of hepatocytes after massive hepatectomy in rats, reflected by the elevated PCNA-positive cells ([@b33-ijsc_07_87]).

Conclusion
==========

From the previously discussed results, it was concluded that BM-MSCs markedly decreased the induced liver fibrosis by CCL~4~ in albino rats. So, stem cell therapy offers a hope to patient waiting for liver transplantation. Further studies on the differentiation of MSCs into hepatocytes in vitro and their use in treatment of liver fibrosis were recommended.
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![(A) Showing radiating cords of hepatocytes from the central vein (C.V.). The hepatocytes have central, rounded, vesicular nuclei (↑) and acidophilic cytoplasm. Some of the cells appear bi-nucleated (▲). Notice the lining cells ( ![](ijsc_07_87i2.jpg)) of the blood sinusoids (control H and E. ×720). (B) Most of the hepatocytes are vacuolated ( ![](ijsc_07_87i1.jpg)). Few hepatocytes appear with acidophilic cytoplasm and deeply stained nuclei (▲) (CCL~4~ alone group. H and E. ×560). (C) Most of the hepatocytes have granular acidophilic cytoplasm and vesicular nuclei. Few cells show cytoplasmic vacuolation (↑) (CCL~4~/MSCs group. H and E. ×560). (D) Showing highly vacuolated hepatocytes with deeply stained nuclei (↑) (CCL~4~/Recovery group, H and E. ×400).](ijsc_07_87f1){#f1-ijsc_07_87}

![(A) Showing few collagen fibers ( ![](ijsc_07_87i1.jpg)) surrounding the central vein (V), in portal area (P) and in the capsule (C) in Control group. (B) Showing numerous collagen fibers ( ![](ijsc_07_87i1.jpg)) surrounding the central veins (V), in portal area (P) and in the capsule (C) in CCL~4~ alone group. (C) Showing the collagen fibers of CCL~4~/MSCs group which are comparable to that of the control group. (D) Showing numerous collagen fibers (↑) surrounding the central veins (V), in portal area (P) and in the capsule (C) in CCL~4~/Recovery group (Masson's trichrome V×400, P×400, C×140).](ijsc_07_87f2){#f2-ijsc_07_87}

![(A) Showing few *α*-SMA positive cells ( ![](ijsc_07_87i1.jpg)) around the central vein and in-between the hepatocytes (control group×560). (B) Showing an apparent increase in *α*-SMA positive cells ( ![](ijsc_07_87i1.jpg)) around central vein, in septa between the hepatic lobules and in-between the hepatocytes. Inset: *α*-SMA positive cells appear spindle in shape with cytoplasmic processes (CCL~4~ alone group×400--inset×560). (C) Showing few *α*-SMA positive cells ( ![](ijsc_07_87i1.jpg)) around the central vein and in-between the hepatocytes (CCL~4~/MSCs group×560). (D) Showing strong positive immune reaction for *α*-SMA ( ![](ijsc_07_87i1.jpg)) around the central vein and in-between the hepatocytes (CCL~4~/Recovery group×400). Immunostaining for *α*-SMA.](ijsc_07_87f3){#f3-ijsc_07_87}

![(A) Showing few hepatocytes with positive immune reaction for PCNA ( ![](ijsc_07_87i1.jpg)) in control group. (B) Showing few hepatocytes with positive immune reaction for PCNA ( ![](ijsc_07_87i1.jpg)) in CCL~4~ alone group. (C) Showing many of PCNA positive hepatocytes ( ![](ijsc_07_87i1.jpg)) in CCL~4~/MSCs group. (D) Showing few hepatocytes with positive immune reaction for PCNA ( ![](ijsc_07_87i1.jpg)) in CCL~4~/Recovery group (Immunostaining for PCNA, ×560).](ijsc_07_87f4){#f4-ijsc_07_87}

![(A) Showing adjacent hepatocytes with sinusoidal spaces (S) in-between. HSCs (\*) are seen in the perisinusoidal space The hepatocytes appear with large rounded, central vesicular nuclei (N). The nuclei show usual characteristic chromatin distribution. The cytoplasm contains numerous mitochondria (M), rER ( ![](ijsc_07_87i1.jpg)) and fat droplets (▲) (Control group TEM×4050). (B) Showing adjacent hepatocytes. The nuclei of the hepatocytes show abnormal chromatin distribution (N). The cytoplasm contains multiple vacuoles ( ![](ijsc_07_87i1.jpg)) and fat droplets (▲) (CCL~4~ alone group TEM ×4050).](ijsc_07_87f5){#f5-ijsc_07_87}

![(A) Showing hepatocytes (white ![](ijsc_07_87i1.jpg)) that are comparable to that of the control group. They contain many mitochondria and show usual distribution of chromatin in their nuclei (N). Small vacuoles ( ![](ijsc_07_87i1.jpg)) and few fat droplets (▲) are seen in some hepatocytes (CCL~4~/MSCs group TEM×4050). (B) Showing irregular large vacuoles (▲) and fat droplets ( ![](ijsc_07_87i1.jpg)) inside the cytoplasm of hepatocytes. The nuclei appear with abnormal chromatin distribution (N). Notice the presence of HSCs (\*) with euchromatic nuclei in between hepatocytes (CCL~4~/Recovery group TEM×4050).](ijsc_07_87f6){#f6-ijsc_07_87}

![Showing presence of Y chromosomes in male rats from which BM-MSCs were isolated (lane 1) and female rats treated with BM-MSCs in CCL~4~/MSCs group (lane 4). Y chromosome marker is not detecting in female rats of the control group (lane 2), CCL~4~ alone group (lane 3) and CCL~4~/recovery group (lane 5). M: PCR marker (U.V. trans-illuminated agarose gel of PCR products of SRY gene).](ijsc_07_87f7){#f7-ijsc_07_87}

###### 

Showing changes in area percentage of collagen, *α* smooth muscle actin, mean number of PCNA positive cells/high power field (HPFs) and biochemical measurements (ALT, AST and albumin) in different groups

                                                   Control group                                                                                       CCL~4~ alone group                                                                                                                            CCL~4~/MSCs group                                                                                                                              CCL~4~/Recovery group
  ------------------------------------------------ --------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------
  Area percentage of collagen fibers (%)           14.4±2.8 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})     74.4±4.47 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})   21.5±4.7 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})                                                85.5±3.6 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[■](#tfn2-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})
  Area percentage of *α* smooth muscle actin (%)   14.67±3.33 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})   41.43±2.1 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})   18.4±3.8 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})                                                58.26±4.09 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[■](#tfn2-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})
  Number of PCNA/HPFs                              2.04±0.96 ([▲](#tfn3-ijsc_07_87){ref-type="table-fn"})                                              1.02±1.03 ([▲](#tfn3-ijsc_07_87){ref-type="table-fn"})                                                                                        10.09±1.47 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})   1.21±0.03 ([▲](#tfn3-ijsc_07_87){ref-type="table-fn"})
  ALT (*μ*/L)                                      57.4±6.8 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})     112.6±16.1 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})                                            64.1±9.2 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})                                                109.1±15.75 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})
  AST (*μ*/L)                                      37.2±3.4 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})     431.7±14.2 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})                                            46.5±4.7 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})                                                434.7±16.15 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})
  ALBUMIN (g/dL)                                   3.65±0.5 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})     1.98±0.66 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})                                             3.73±0.34 ([■](#tfn2-ijsc_07_87){ref-type="table-fn"}[○](#tfn4-ijsc_07_87){ref-type="table-fn"})                                               1.72±0.53 ([\*](#tfn1-ijsc_07_87){ref-type="table-fn"}[▲](#tfn3-ijsc_07_87){ref-type="table-fn"})

Significant difference from Control group,

Significant difference from CCL~4~ alone group,

Significant difference from CCL~4~/MSCs group,

Significant difference from CCL~4~/Recovery group.
